2022. The expression of VISTA on CD4+ T cells associate with poor prognosis and immune status in non-small cell lung cancer patients. Biomolecules and Biomedicine. 22, 5 (Sep. 2022), 707–715. DOI:https://doi.org/10.17305/bjbms.2021.6531.